نتایج جستجو برای: hemagglutinin ha

تعداد نتایج: 66356  

Journal: :Science 2015
Antonietta Impagliazzo Fin Milder Harmjan Kuipers Michelle V Wagner Xueyong Zhu Ryan M B Hoffman Ruud van Meersbergen Jeroen Huizingh Patrick Wanningen Johan Verspuij Martijn de Man Zhaoqing Ding Adrian Apetri Başak Kükrer Eveline Sneekes-Vriese Danuta Tomkiewicz Nick S Laursen Peter S Lee Anna Zakrzewska Liesbeth Dekking Jeroen Tolboom Lisanne Tettero Sander van Meerten Wenli Yu Wouter Koudstaal Jaap Goudsmit Andrew B Ward Wim Meijberg Ian A Wilson Katarina Radošević

The identification of human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin (HA) stem revitalized hopes of developing a universal influenza vaccine. Using a rational design and library approach, we engineered stable HA stem antigens ("mini-HAs") based on an H1 subtype sequence. Our most advanced candidate exhibits structural and bnAb binding properties comparable to those of...

2016
Hyunkyung Kang Hang Sik Roh Hyemin Song Kwangmoon Lee Seung-Tae Chung Sang-ja Ban In Pil Mo Beum-Soo An Chi-Young Ahn

The potency of influenza vaccine is determined based on its hemagglutinin (HA) content. In general, single radial immunodiffusion (SRID) assay has been utilized as the standard method to measure HA content. However, preparation of reagents for SRID such as antigen and antibody takes approximately 2~3 months, which causes delays in the development of influenza vaccine. Therefore, quantification ...

Journal: :Science 2013
Yi Shi Wei Zhang Fei Wang Jianxun Qi Ying Wu Hao Song Feng Gao Yuhai Bi Yanfang Zhang Zheng Fan Chengfeng Qin Honglei Sun Jinhua Liu Joel Haywood Wenjun Liu Weimin Gong Dayan Wang Yuelong Shu Yu Wang Jinghua Yan George F Gao

An avian-origin human-infecting influenza (H7N9) virus was recently identified in China. We have evaluated the viral hemagglutinin (HA) receptor-binding properties of two human H7N9 isolates, A/Shanghai/1/2013 (SH-H7N9) (containing the avian-signature residue Gln(226)) and A/Anhui/1/2013 (AH-H7N9) (containing the mammalian-signature residue Leu(226)). We found that SH-H7N9 HA preferentially bin...

Journal: :Journal of virology 1999
A Roberts L Buonocore R Price J Forman J K Rose

We showed previously that a single intranasal vaccination of mice with a recombinant vesicular stomatitis virus (VSV) expressing an influenza virus hemagglutinin (HA) protein provided complete protection from lethal challenge with influenza virus (A. Roberts, E. Kretzschmar, A. S. Perkins, J. Forman, R. Price, L. Buonocore, Y. Kawaoka, and J. K. Rose, J. Virol. 72:4704-4711, 1998). Because some...

Journal: :Applied and environmental microbiology 2014
Narjol Gonzalez-Escalona Ruth Timme Brian H Raphael Donald Zink Shashi K Sharma

Clostridium botulinum is a genetically diverse Gram-positive bacterium producing extremely potent neurotoxins (botulinum neurotoxins A through G [BoNT/A-G]). The complete genome sequences of three strains harboring only the BoNT/A1 nucleotide sequence are publicly available. Although these strains contain a toxin cluster (HA(+) OrfX(-)) associated with hemagglutinin genes, little is known about...

2010
Suman R. Das Pere Puigbò Scott E. Hensley Darrell E. Hurt Jack R. Bennink Jonathan W. Yewdell

Antigenic drift in the influenza A virus hemagglutinin (HA) is responsible for seasonal reformulation of influenza vaccines. Here, we address an important and largely overlooked issue in antigenic drift: how does the number and location of glycosylation sites affect HA evolution in man? We analyzed the glycosylation status of all full-length H1 subtype HA sequences available in the NCBI influen...

Journal: :The Journal of infectious diseases 2006
John J Treanor Gilbert M Schiff Robert B Couch Thomas R Cate Rebecca C Brady C Mhorag Hay Mark Wolff Dewei She Manon M J Cox

BACKGROUND Influenza-virus hemagglutinin (HA) protein expressed in insect cells by recombinant baculovirus is a candidate influenza vaccine. METHODS In a randomized, double-blind trial conducted in 399 adults > or = 65 years of age, the efficacy of trivalent inactivated influenza vaccine (TIV) licensed for intramuscular injection was compared with that of trivalent baculovirus-expressed HA va...

Journal: :Acta naturae 2016
D N Shcherbinin S V Alekseeva M M Shmarov Yu A Smirnov B S Naroditskiy A L Gintsburg

Vaccination has been successfully used to prevent influenza for a long time. Influenza virus hemagglutinin (HA), which induces a humoral immune response in humans and protection against the flu, is the main antigenic component of modern influenza vaccines. However, new seasonal and pandemic influenza virus variants with altered structures of HA occasionally occur. This allows the pathogen to av...

Journal: :The Journal of biological chemistry 1994
H Y Naim M G Roth

Several proteins, including the hemagglutinin (HA)-Y543 mutant influenza virus hemagglutinin, are internalized by clathrin-coated pits but do not have a sequence that fits a recently proposed consensus for internalization signals containing tyrosine. To determine whether or not the HA-543 signal is a degenerate form of the internalization signal found in proteins such as the transferrin recepto...

Journal: :Journal of virology 2015
Peter H Goff Tomoko Hayashi Luis Martínez-Gil Maripat Corr Brian Crain Shiyin Yao Howard B Cottam Michael Chan Irene Ramos Dirk Eggink Mitra Heshmati Florian Krammer Karen Messer Minya Pu Ana Fernandez-Sesma Peter Palese Dennis A Carson

UNLABELLED Current vaccines against influenza virus infection rely on the induction of neutralizing antibodies targeting the globular head of the viral hemagglutinin (HA). Protection against seasonal antigenic drift or sporadic pandemic outbreaks requires further vaccine development to induce cross-protective humoral responses, potentially to the more conserved HA stalk region. Here, we present...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید